Sex
Visit (Number) vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline (BL) | - | - | - | - | - | - | 1,516 | 1,516 |
Clinical Evaluation (CE) | - | - | - | - | - | - | 1,516 | 1,516 |
Diagnostic Visit (DX) | 1,199 | 1.9 | ± 4.3 | 1.0 | -22.0 | 82.0 | 317 | 1,516 |
CPAP Titration Visit (CPAP) | - | - | - | - | - | - | 1,516 | 1,516 |
Two Month Post-CPAP Neurocognitive Visit (2M) | 877 | 1.7 | ± 3.8 | 1.0 | -22.0 | 63.0 | 639 | 1,516 |
Four Month Post-CPAP Neurocognitive Visit (4M) | - | - | - | - | - | - | 1,516 | 1,516 |
Six Month Post-CPAP Neurocognitive Visit (6M) | 848 | 1.8 | ± 3.6 | 1.0 | -22.0 | 43.0 | 668 | 1,516 |
Gender vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,199 | 1.9 | ± 4.3 | 1.0 | -22.0 | 82.0 | 317 | 1,516 |
Male | 767 | 1.8 | ± 4.5 | 1.0 | -22.0 | 82.0 | 191 | 958 |
Female | 432 | 2.3 | ± 3.9 | 1.0 | -22.0 | 32.0 | 126 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 877 | 1.7 | ± 3.8 | 1.0 | -22.0 | 63.0 | 639 | 1,516 |
Male | 569 | 1.5 | ± 3.7 | 1.0 | 0.0 | 63.0 | 389 | 958 |
Female | 308 | 2.0 | ± 4.0 | 1.0 | -22.0 | 37.0 | 250 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Male | - | - | - | - | - | - | 958 | 958 |
Female | - | - | - | - | - | - | 558 | 558 |
Gender vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 848 | 1.8 | ± 3.6 | 1.0 | -22.0 | 43.0 | 668 | 1,516 |
Male | 550 | 1.6 | ± 3.1 | 1.0 | 0.0 | 42.0 | 408 | 958 |
Female | 298 | 2.1 | ± 4.4 | 1.0 | -22.0 | 43.0 | 260 | 558 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Baseline (BL)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Clinical Evaluation (CE)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Diagnostic Visit (DX)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 1,199 | 1.9 | ± 4.3 | 1.0 | -22.0 | 82.0 | 317 | 1,516 |
Native American | 20 | 2.7 | ± 6.2 | 0.5 | 0.0 | 28.0 | 8 | 28 |
Asian | 71 | 2.2 | ± 4.9 | 1.0 | 0.0 | 32.0 | 18 | 89 |
Black | 115 | 2.5 | ± 3.4 | 1.0 | 0.0 | 18.0 | 57 | 172 |
Hispanic | 83 | 2.8 | ± 9.2 | 1.0 | 0.0 | 82.0 | 33 | 116 |
White | 902 | 1.8 | ± 3.6 | 1.0 | -22.0 | 62.0 | 200 | 1,102 |
Other | 8 | 1.3 | ± 2.1 | 0.0 | 0.0 | 6.0 | 1 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
CPAP Titration Visit (CPAP)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Two Month Post-CPAP Neurocognitive Visit (2M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 877 | 1.7 | ± 3.8 | 1.0 | -22.0 | 63.0 | 639 | 1,516 |
Native American | 13 | 4.0 | ± 4.6 | 3.0 | 0.0 | 17.0 | 15 | 28 |
Asian | 48 | 1.5 | ± 3.1 | 0.0 | 0.0 | 19.0 | 41 | 89 |
Black | 76 | 1.0 | ± 3.3 | 1.0 | -22.0 | 9.0 | 96 | 172 |
Hispanic | 65 | 3.3 | ± 9.2 | 1.0 | 0.0 | 63.0 | 51 | 116 |
White | 672 | 1.6 | ± 2.9 | 1.0 | 0.0 | 36.0 | 430 | 1,102 |
Other | 3 | 2.3 | ± 2.5 | 2.0 | 0.0 | 5.0 | 6 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Four Month Post-CPAP Neurocognitive Visit (4M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | - | - | - | - | - | - | 1,516 | 1,516 |
Native American | - | - | - | - | - | - | 28 | 28 |
Asian | - | - | - | - | - | - | 89 | 89 |
Black | - | - | - | - | - | - | 172 | 172 |
Hispanic | - | - | - | - | - | - | 116 | 116 |
White | - | - | - | - | - | - | 1,102 | 1,102 |
Other | - | - | - | - | - | - | 9 | 9 |
Race/Ethnicity vs Psychomotor Vigilance Test (PVT) Total Lapse Counts (>=500 msec)
Six Month Post-CPAP Neurocognitive Visit (6M)
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 848 | 1.8 | ± 3.6 | 1.0 | -22.0 | 43.0 | 668 | 1,516 |
Native American | 13 | 1.9 | ± 2.0 | 1.0 | 0.0 | 6.0 | 15 | 28 |
Asian | 50 | 1.4 | ± 2.6 | 1.0 | 0.0 | 14.0 | 39 | 89 |
Black | 75 | 2.5 | ± 5.6 | 1.0 | 0.0 | 42.0 | 97 | 172 |
Hispanic | 61 | 2.4 | ± 3.9 | 1.0 | 0.0 | 23.0 | 55 | 116 |
White | 646 | 1.7 | ± 3.4 | 1.0 | -22.0 | 43.0 | 456 | 1,102 |
Other | 3 | 1.0 | ± 1.7 | 0.0 | 0.0 | 3.0 | 6 | 9 |